News
Category
-
Business Wire
CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs
March 20, 2023 -
Business Insider
We got the presentation health-tech veteran Jonathan Bush used to land $40 million for his new startup Zus Health
March 16, 2023 -
PR Newswire
Zus Health Closes Financing, Signs Partnership with Elation Health, to Accelerate Growth of its Data Service to Provide Connective Tissue for Healthcare
March 16, 2023 -
Business Wire
SpectrumAi Secures up to $20M Series A Investment
March 16, 2023 -
PR Newswire
Adela to present data demonstrating detection of multiple cancer types at the American Association for Cancer Research Annual Meeting 2023
March 14, 2023 -
GenomeWeb
New Products Posted to GenomeWeb: Cytek Biosciences, Thermo Fisher Scientific, Bruker
March 10, 2023 -
BioNews, Inc.
AviadoBio acquires rights to gene therapies’ new delivery technology
March 9, 2023 -
Fierce Biotech
Capital Rx CEO: PBM industry needs to be repaired, not ditched
March 9, 2023 -
San Francisco Business Times
Cancer, biosimilar drug maker Coherus shedding more biotech jobs
March 9, 2023 -
Business Wire
CareStack’s All-in-One Dental Software Gets AI Upgrade with Pearl Partnership
March 9, 2023 -
PR Newswire
Centivo Partnership with the Business Health Care Group Reports More Effective Utilization of Health Benefits, Leading to 23 to 36 Percent Cost Savings for Employers and Health Plan Members
March 9, 2023 -
PR Newswire
Capital Rx is Now Part of the B Corp™ Movement, Reinforcing its Commitment to Advancing Equity in Pharmacy Benefits
March 8, 2023 -
Business Wire
James D. Swift, M.D., Elected to Pediatrix Board of Directors
March 8, 2023 -
Globenewswire
Cytek® Biosciences Introduces New 20-Color AML Panel
March 7, 2023 -
PR Newswire
Capital Rx Named to the Forbes Best Startup Employers 2023 List
March 7, 2023 -
PR Newswire
Papaya Global Launches First and Only Embedded Payments Platform Built for Global Workforce Payroll Payments
March 7, 2023 -
Business Wire
Rallybio Announces Proof-of-Concept Achieved for RLYB212, a Novel Monoclonal anti-HPA-1a Antibody to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia
March 6, 2023 -
Business Wire
TandemAI Raises $35 Million in Series A Financing to Expand Integrated Computational and Wet Lab Solutions to Accelerate Drug Discovery
March 1, 2023 -
PR Newswire
Capital Rx Ranks in the Top 50 on Inc. Magazine’s List of the Northeast Region’s Fastest-Growing Private Companies for the Second Year in a Row
February 28, 2023 -
Business Wire
Third Annual Science2Startup (S2S)™ Symposium on May 3, 2023 Will Foster Collaboration Between Researchers, Entrepreneurs and Top Investors
February 28, 2023 -
Globenewswire
Orchard Therapeutics Announces Agreement Enabling Reimbursed Access to Libmeldy for All Eligible MLD Patients in Sweden
February 27, 2023 -
PR Newswire
Innovent Announces First Participant Dosed in Phase 1 Clinical Study of IBI333 (VEGF-A/VEGF-C Bispecific Fusion Protein) in Patients with Neovascular Age-related Macular Degeneration
February 27, 2023 -
Business Wire
EyePoint and Rallybio Announce Research Collaboration to Evaluate Rallybio’s Inhibitor of Complement Component 5 (C5) and EyePoint’s Proprietary Durasert® Technology for Sustained Intraocular Delivery in Geographic Atrophy
February 27, 2023 -
Business Wire
Engooden Health Taps Healthcare Executive Tom Frosheiser as CEO
February 21, 2023 -
Fast Company
This startup just raised more than half a billion dollars to change how new drugs get discovered
February 19, 2023 -
Fierce Pharma
Apellis wins FDA approval for first geographic atrophy drug
February 17, 2023 -
Globenewswire
Denali Therapeutics Announces Presentations on Enzyme Transport Vehicle (ETV) Development Programs for MPS Diseases at the Upcoming WORLDSymposium™
February 15, 2023 -
Fierce Biotech
New biotech VC takes off with $520M and a flight deck stacked with big-name investors ready to serve
February 14, 2023 -
The Guardian
Girl with deadly inherited condition is cured with gene therapy on NHS
February 14, 2023 -
Precision Oncology News
Owkin-led Machine Learning Study IDs Possible Cancer Treatment Biomarkers Using Federated Model
February 14, 2023 -
Globenewswire
Verve Therapeutics Announces VERVE-101 Awarded Innovation Passport by the UK MHRA for the Treatment of Heterozygous Familial Hypercholesterolemia
February 14, 2023 -
PR Newswire
Innovent Announces First Participant Dosed in Phase 2 Study of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Associated Ophthalmopathy
February 14, 2023 -
Globenewswire
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023 -
PR Newswire
Capital Rx Earns Surescripts® Certification & SOC 2 Type 2 Report
February 10, 2023 -
Business Wire
Ensoma Announces Closing of Twelve Bio Acquisition
February 9, 2023 -
Endpoints News
The top 100 venture investors in biopharma today. Who’s staying at the deals table?
February 9, 2023 -
GlobeNewswire
Protenus is Top Performing Solution in Two Segments Based on 2023 Best in KLAS Report
February 8, 2023 -
GlobeNewswire
Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
February 8, 2023 -
Axios
Exclusive: Blackstone, Carlyle-backed Canoe raises $25M
February 8, 2023 -
GlobeNewswire
Structure Therapeutics Announces Pricing of Upsized Initial Public Offering
February 2, 2023 -
The White House
The White House highlights Owkin and CancerLinQ collaboration as part of its Cancer Moonshot
February 2, 2023 -
Globenewswire
Denali Therapeutics Announces New Interim Data from DNL310 Phase 1/2 Study for MPS II and DNL126 Preclinical Data for MPS IIIA at WORLDSymposium™
February 2, 2023 -
PR Newswire
Capital Rx is Honored to be Named to the 2023 New York Digital Health 100
February 1, 2023 -
GlobeNewswire
Insilico Medicine Opens Largest AI-Powered Biotechnology Research Center in the Middle East
February 1, 2023 -
Business Wire
NOCD Completes Additional Funding in its Quest to End the OCD Crisis
January 31, 2023 -
GlobeNewswire
BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research
January 31, 2023 -
Business Wire
Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
January 31, 2023 -
Business Standard
Enzene Biosciences raises $50 million, aims to expand into global markets
January 30, 2023 -
Paradigm
Paradigm Launches with $203 Million to Rebuild the Clinical Research Ecosystem
January 27, 2023 -
PR Newswire
Stride Health Recognized As One of Built In’s Best Places to Work in 2023
January 26, 2023 -
PR Newswire
Benchling Bolsters Commitment to Security with Type 2 SOC 2
January 26, 2023 -
GlobeNewswire
Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies
January 26, 2023 -
Business Wire
Firefly Health Welcomes Former Massachusetts Lt. Governor Karyn Polito to its Advisory Council
January 25, 2023 -
PR Newswire
Carrot Fertility Exceeds National Benchmarks for Fertility Success, Publishes New, Independently Validated Outcomes Study
January 18, 2023 -
Business Wire
Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors
January 18, 2023 -
PR Newswire
Whatfix ISV Partnership Program Grows Rapidly, Empowering Software Providers to Deliver Better User Experience and Accelerate Customer Adoption
January 12, 2023 -
PR Newswire
Jefferson County to Use Eleos Health’s Augmented Intelligence to Give Therapists More Time to Serve Those With Mental Illness
January 12, 2023 -
GlobeNewswire
Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target
January 10, 2023 -
PR Newswire
Community Services Group Taps Eleos Health for Augmented Intelligence Support in Behavioral Healthcare
January 10, 2023 -
GlobeNewswire
Insilico Medicine launches 6th generation Intelligent Robotics Lab to further accelerate its AI-driven drug discovery
January 5, 2023 -
Business Wire
X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership
January 5, 2023 -
Business Wire
Ensoma Announces $85 Million Financing and Agreement to Acquire Twelve Bio to Advance Portfolio of In Vivo Engineered Cellular Medicines
January 5, 2023 -
GlobeNewswire
Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
January 5, 2023 -
PR Newswire
Innovent Announces NMPA’s Breakthrough Therapy Designation for IBI351 (KRAS G12C Inhibitor) as Monotherapy for Previous Treated Advanced Non-small Cell Lung Cancer
January 4, 2023 -
PR Newswire
Patina announces partnerships with major national Medicare Advantage plans, significantly expanding the reach of its unique primary care experience for adults 65+ in Philadelphia region
December 15, 2022 -
Business Wire
Rallybio Announces Publication of Data Highlighting the Ability of HPA-1a-Specific Antibodies to Prevent Alloimmunization in an Authentic Mouse Model of FNAIT
December 15, 2022 -
PR Newswire
Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer
December 15, 2022 -
PR Newswire
Alternative Bio Launches with USD 15M Series Seed Financing Led by Eight Roads Ventures with F-Prime Capital and Sequoia China Seed Fund
December 14, 2022 -
EZ Newswire
Immuneel Therapeutics Presents Early Data from India for Varnimcabtagene Autoleucel at ASH Annual Meeting
December 14, 2022 -
PR Newswire
ABK Biomedical Raises USD 30M in Series C Financing
December 6, 2022 -
GlobeNewswire
Pulmocide Raises $52 Million to Fund Additional Late-Stage Development of Opelconazole
December 6, 2022 -
GlobeNewswire
Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial
December 5, 2022 -
GlobeNewswire
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022
December 2, 2022 -
GlobeNewswire
Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201
December 2, 2022 -
Endpoints
Rallybio, AbCellera form new partnership around antibodies for rare disease
December 1, 2022 -
GlobeNewswire
Protenus CTO Michael Baglio Wins Top Healthcare Tech CTO Award
November 29, 2022 -
Business Wire
NOCD Educates Record Number of People During 2022 OCD Awareness Month
November 23, 2022 -
PR Newswire
AllHealth Network Selects Eleos Health to Deliver In-Session Automation, Reducing Clinician Burden and Improving Care
November 22, 2022 -
PR Newswire
Adela’s Co-Founder & Chief Scientific Officer to Deliver Plenary Session at American Association for Cancer Research (AACR) Special Conference on Precision Prevention, Early Detection, and Interception of Cancer
November 15, 2022 -
Fierce Healthcare
SonderMind picks up neuroscience company Total Brain to build out data-driven mental healthcare
November 15, 2022 -
PR Newswire
Centivo’s Virtual Primary Care practice receives NCQA Patient-Centered Medical Home Recognition
November 15, 2022 -
PR Newswire
Capital Rx is Crowned Winner of the Fierce Healthcare Fierce Innovation Award
November 15, 2022 -
PR Newswire
Deal Engine Raises $5.3M to Simplify Post-Booking Travel Transactions
November 15, 2022 -
PR Newswire
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
November 14, 2022 -
News wise
RareCyte® selected for the Wellcome Leap In Utero program; will utilize its rare cell liquid biopsy platform to perform breakthrough research to decrease stillbirth rates worldwide
November 14, 2022 -
GlobeNewswire
Denali Therapeutics Announces Phase 1/2 Study Single Dose Healthy Volunteer Data with TAK-594/DNL593 (PTV:PGRN) and Progression to Enrolling Participants with FTD-GRN
November 1, 2022 -
Business Wire
Turnstone Biologics Announces FDA Clearance of IND for TIDAL-01, a Next-Generation TIL Therapy for Solid Tumors
October 31, 2022 -
GlobeNewswire
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022 -
PR Newswire
Innovent Announces First Patient Dosing in Australia in Phase I Study of IBI343 (Recombinant anti-Claudin18.2 Monoclonal Antibody-drug Conjugate) in Patients with Advanced Solid Tumors
October 30, 2022 -
Business Wire
ConnexPay Secures $110 Million Growth Investment Led by FTV Capital to Propel Global Expansion and Unify Payments Ecosystem
October 25, 2022